Amylyx Pharmaceuticals
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts. Founded in 2013 by Joshua Cohen, Justin Klee, and Kent Leslie, the company focuses on developing innovative therapies for neurodegenerative diseases and other challenging medical conditions. Their mission is to address significant unmet medical needs through rigorous scientific research and a deep understanding of the communities they serve. The company is advancing several investigational therapies, including Avexitide for post-bariatric hypoglycemia and congenital hyperinsulinism, AMX0035 for Wolfram syndrome and progressive supranuclear palsy, and AMX0114 for amyotrophic lateral sclerosis. Amylyx collaborates closely with the ALS community and various stakeholders in the medical field to enhance its research and development efforts. With a commitment to innovation and improving patient outcomes, Amylyx Pharmaceuticals is expanding its global presence, including a recent establishment of a subsidiary in Japan.
Work at Amylyx Pharmaceuticals in HR or recruiting? Claim this page
Headcount trend
Amylyx Pharmaceuticals went from 133 employees in Oct 2024 to 166 in Sep 2026. Apr to Sep 2026: 24 people joined, 4 left.
Org structure
Headcount by department
Peer reviews
Worked with someone at Amylyx Pharmaceuticals?
Anonymous peer reviews on OffTheRecord
Similar companies
Hiring now
Base Salary:
$210k - $240k
Base Salary:
$178k - $200k
Base Salary:
$156k - $176k
Base Salary:
$303k - $341k
Base Salary:
$200k - $225k
Base Salary:
$200k - $225k
Base Salary:
$200k - $225k
Base Salary:
$200k - $225k
Amylyx Pharmaceuticals FAQ
How many employees does Amylyx Pharmaceuticals have?
Amylyx Pharmaceuticals has about 166 employees, up 5.7% over the 3 months to Sep 2026.
What is Amylyx Pharmaceuticals's revenue per employee?
Amylyx Pharmaceuticals makes about $527K in revenue per employee, based on $87.4M annual revenue and 166 employees.
Is Amylyx Pharmaceuticals a public company?
Yes. Amylyx Pharmaceuticals is publicly traded under the ticker AMLX on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.